Protein Ki-67 and collagen iv in diagnosis in prostatic neoplasms


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

Aim. Assessment of prostatic expression of protein KI-67 and collagen IV in benign prostatic hyperplasia and prostatic cancer. Methods. Specimes of prostatic tissue of 53 patients (age 52-83 years) with prostatic adenocarcinoma and 10 -with benign prostatic hyperplasia were analysed. All patients were BIOPSIED in 2010-2014 years. Results. High expression of collagen IV was found in benign prostatic hyperplasia, in prostatic adenocarcinoma expression of collagen IV was low. Glisson scale stage corellated with cell proliferation index according to KI-67 expression (rs =0,674). Conclusion. Measurement of KI-67 expression can be used in differential diagnosis between benign prostatic hyperplasia and prostatic adenocarcinoma.

Full Text

Restricted Access

References

  1. De la Rosette J., Alivizatos G., Madersbacher S. et al. Guidelines on Benign Prostatic Hyperplasia European Association of Urology. 2009.
  2. Аполихин О.И., Сивков А.В., Бешлиев Д.А. и др. Анализ урологической заболеваемости в Российской Федерации в 2002-2009 гг., по данным официальной статистики // Экспериментальная и клиническая урология. - 2011. - № 1. С. 4-10.
  3. Siegel R., Naishadham D., Jemal A. Cancer statistics, 2012. CA Cancer J. Clin. - 2012. Vol. 62. - P. 10-29.
  4. Лопаткин Н.А., Максимов В.А., Ходырева Л.А., Давыдова Е.Н. Оптимизация ранней диагностики заболеваний предстательной железы в условиях мегаполиса // Урология. - 2009. № 5. - С. 50-54.
  5. O'Shaughnessy M., Konety B., Warlick C. Prostate cancer screening: issues and controversies// Minn. Med. - 2010. Vol. 93. - P. 39-44.
  6. Fisher G., Yang Z.N., Kudahetti S., Scardino P. Prognostic value of Ki-67 for prostate cancer death in a conservatively managed cohort. // Br. J. Cancer. - 2013. Vol. 108(2). - P. 271-277.

Supplementary files

Supplementary Files
Action
1. JATS XML

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies